Nederby Line相关文献与解析，生知库 | 链接生命科学的每一步

Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study

接受根治性放疗（伴或不伴雄激素剥夺疗法）治疗的前列腺癌患者的自然杀伤细胞活性：一项观察性研究

期刊:Acta Oncologica

影响因子:2.2

doi:10.2340/1651-226X.2025.44007

Eriksen, Stine V; Madsen, Christine V; Timm, Signe; Zedan, Ahmed H; Raunkilde, Louise; Hansen, Torben F; Nederby, Line

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.

可溶性程序性死亡配体 1 作为接受纳武利尤单抗、帕博利珠单抗或阿特珠单抗治疗的非小细胞肺癌患者的预后生物标志物

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-59791-0

Brun Sinne SÃ¸berg, Hansen Torben FrÃ¸strup, Wen Sara Witting Christensen, Nyhus Christa Haugaard, Bertelsen Lisbeth, Jakobsen Anders, Hansen Torben SchjÃ¸dt, Nederby Line

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

NK细胞活性和甲基化HOXA9 ctDNA作为PD-1/PD-L1抑制剂治疗的非小细胞肺癌患者的预后生物标志物

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-023-02285-z

Wen, Sara Witting Christensen; Nederby, Line; Andersen, Rikke Fredslund; Hansen, Torben Schjødt; Nyhus, Christa Haugaard; Hilberg, Ole; Jakobsen, Anders; Hansen, Torben Frøstrup

Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort

评估循环生物标志物在肺癌高危人群检测中的应用

期刊:Cancer Biomarkers

影响因子:1.9

doi:10.3233/CBM-210543

Borg, Morten; Nederby, Line; Wen, Sara Witting Christensen; Hansen, Torben Frøstrup; Jakobsen, Anders; Andersen, Rikke Fredslund; Weinreich, Ulla Møller; Hilberg, Ole

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients

自然杀伤细胞活性作为高危患者肺癌诊断的生物标志物

期刊:Journal of International Medical Research

影响因子:1.5

doi:10.1177/03000605221108924

Borg, Morten; Wen, Sara Witting Christensen; Hansen, Torben Frøstrup; Jakobsen, Anders; Andersen, Rikke Fredslund; Hilberg, Ole; Weinreich, Ulla Møller; Nederby, Line

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

基线T细胞、B细胞和中性粒细胞-淋巴细胞比值（NLR）在接受化疗的复发性卵巢癌中的预后意义

期刊:Journal of Ovarian Research

影响因子:4.2

doi:10.1186/s13048-020-00661-4

Henriksen, Jon Røikjær; Nederby, Line; Donskov, Frede; Waldstrøm, Marianne; Adimi, Parvin; Jakobsen, Anders; Steffensen, Karina Dahl

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

自然杀伤细胞活性与转移性癌症患者治疗效果的相关性

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2019.04.002

Hansen, Torben Frøstrup; Nederby, Line; Zedan, Ahmed H; Mejlholm, Inge; Henriksen, Jon R; Steffensen, Karina D; Thomsen, Caroline B; Raunkilde, Louise; Jensen, Lars Henrik; Jakobsen, Anders

Case report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy

病例报告：外显子组测序鉴定出具有髓系特征的T细胞急性淋巴细胞白血病（T-ALL）为IKZF1突变的早期前体T细胞恶性肿瘤

期刊:Leukemia Research Reports

影响因子:0.9

doi:10.1016/j.lrr.2017.11.002

Hansen, Marcus C; Nederby, Line; Kjeldsen, Eigil; Petersen, Marianne A; Ommen, Hans B; Hokland, Peter

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research

用于改进癌症研究中全外显子组测序变异注释和选择的新型脚本

期刊:MethodsX

影响因子:1.9

doi:10.1016/j.mex.2015.03.003

Hansen, Marcus Celik; Nederby, Line; Roug, Anne; Villesen, Palle; Kjeldsen, Eigil; Nyvold, Charlotte Guldborg; Hokland, Peter

Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients

乳腺癌患者自然杀伤细胞活性及对新辅助治疗的反应

Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study

接受根治性放疗（伴或不伴雄激素剥夺疗法）治疗的前列腺癌患者的自然杀伤细胞活性：一项观察性研究

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.

可溶性程序性死亡配体 1 作为接受纳武利尤单抗、帕博利珠单抗或阿特珠单抗治疗的非小细胞肺癌患者的预后生物标志物

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

NK细胞活性和甲基化HOXA9 ctDNA作为PD-1/PD-L1抑制剂治疗的非小细胞肺癌患者的预后生物标志物

Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort

评估循环生物标志物在肺癌高危人群检测中的应用

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients

自然杀伤细胞活性作为高危患者肺癌诊断的生物标志物

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

基线T细胞、B细胞和中性粒细胞-淋巴细胞比值（NLR）在接受化疗的复发性卵巢癌中的预后意义

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

自然杀伤细胞活性与转移性癌症患者治疗效果的相关性

Case report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy

病例报告：外显子组测序鉴定出具有髓系特征的T细胞急性淋巴细胞白血病（T-ALL）为IKZF1突变的早期前体T细胞恶性肿瘤

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research

用于改进癌症研究中全外显子组测序变异注释和选择的新型脚本